Correlation Between Stoke Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Stoke Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Stoke Therapeutics and Pieris Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Pieris is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Pieris Pharmaceuticals. In addition to that, Stoke Therapeutics is 1.7 times more volatile than Pieris Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 1,700 in Pieris Pharmaceuticals on August 28, 2024 and sell it today you would lose (16.00) from holding Pieris Pharmaceuticals or give up 0.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Stoke Therapeutics |
| Pieris Pharmaceuticals |
Stoke Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Stoke Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |